Wren Laboratories Limited
05094520
Healthy
- Going concern doubt noted in accounts (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 05/04/2004
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 79
Also on 2 other boards
director · Since 03/10/2005
BUSINESS DEVELOPMENT
BRITISH · ENGLAND · Age 43
Also on 1 other board
director · Since 08/11/2017
LEARNING & DEVELOPMENT DIRECTOR
BRITISH · ENGLAND · Age 39
Also on 2 other boards
director · Since 08/11/2017
MARKETING DIRECTOR
BRITISH · UNITED KINGDOM · Age 40
Also on 2 other boards
Persons with Significant Control
Medipharma Group Limited
Unit 21-22 Mayfield Avenue Industrial Park, Fyfield Road, Andover, SP11 8HU
Reg: 009966815 · The Register Of Companies In The United Kingdom · Private Company Limited By Shares
Notified 04/09/2018
Former PSCs
Mr Feroze Issa Ismail Janmohamed
Ceased 04/09/2018
Mr Jalal Janmohamed
Ceased 04/09/2018
CompanyRankvs 3925+ SIC 32990 peers60
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to
Key FinancialsYear ending 31/03/2025
Net Worth
£1.4M
Balance sheet strength
Cash
£1.1M
Cash in the bank
Profit Before Tax
£2.0M
Bottom line earnings
Net Current Assets
£281k
Working capital
Current Assets
£6.5M
Current Liabilities
£6.3M
Fixed Assets
£1.1M
Debtors
£2.4M
Cost of Sales
£6.1M
Admin Expenses
£5.2M
Profit After Tax
£1.7M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.04 | +£166k |
| 2024 | 1.26 | -£2.0M |
| 2023 | 2.62 | — |
Derived from filed accounts. Not audited figures.